Colposcopy Market Report and Forecast 2025-2034
Description
The global colposcopy market size was valued at USD 611.82 Million in 2024, driven by the increased prevalence of cervical cancer across the globe. The market is expected to grow at a CAGR of 6.00% during the forecast period of 2025-2034, with the values likely to rise to USD 1095.68 Million by 2034.
Global Colposcopy Market Overview
A colposcopy is a diagnostic procedure to check any abnormal tissue growth in the lower part of the uterus (cervix) and the wall of the vagina. The procedure, usually lasting for 10 to 20 minutes, employs a specialized microscope called a colposcope to magnify the tissue, lining the cervix and vagina. In case any abnormalities are detected, a biopsy is done to test the tissue for precancerous or cancerous cells. Besides checking for cancerous cells, colposcopies can also be used to test for noncancerous growth (polyps), genital warts, vulvar itching, or abnormal vaginal bleeding.
The rising incidence of cervical cancer is acting as the key driver for colposcopy market growth. According to the report released by the World Health Organization (WHO), cervical cancer is the fourth most common cancer in women worldwide. It is also reported that women with human papillomavirus (HPV) are 6 times more prone to cervical cancer as compared to the ones without HPV infection. In addition, it is estimated that around 600,000 women suffer from cervical cancer caused by the sexually transmitted infection HPV, which has prompted the demand for effective screening procedures including colposcopy globally. Moreover, the robust government support to raise awareness about cervical cancers and the importance of colposcopy is expected to bolster the market growth in the coming years.
Development of Novel Colposcopy Products for Cervical Cancer Screening
The recent advancements in technology led to the development of digital and portable colposcopes, facilitating enhanced imaging capabilities and convenience. Additionally, the integration of artificial intelligence (AI) has substantially improved the speed and accuracy of the screening method. This has resulted in a spike in the number of patients opting for the diagnostic procedure, fueling the colposcopy market demand.
In May 2023 , MobileODT, an AI-based FemTech company in Israel introduced EVAPro next gen digital colposcope featuring high image quality with superior software capabilities. The lightweight and portable colposcope utilizes artificial intelligence and machine learning for cervical cancer screening on a large scale, offering quick evaluation (under a minute) and instant consultation. Thus, the novel product redefines cervical cancer screening as compared to the existing standard of care.
Increased Government Initiatives and Awareness Campaigns
Initiatives to raise awareness about the importance of colposcopy for early detection of cervical cancer by government, non-profit organizations, and healthcare facilities have boosted the colposcopy market share significantly.
In May 2023, the National Health Service (NHS), a publicly funded healthcare system in England, pledged to eliminate cervical cancer by 2040. The initiative aims to improve the accessibility of online vaccine appointments and encourage more people to undergo cervical screening, with 3.5 million tested in the last year. With the help of colposcopy teams, and immunization staff, among others, the NHS is actively working towards reducing the global burden of cervical cancer. The robust campaigns are reaching a wider audience, prompting them to adopt regular cervical cancer screening practices, which is likely to contribute to notable market growth in the forecast period.
Global Colposcopy Market Segmentation
Colposcopy Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Instrument Type
North America is anticipated to account for the largest share in the colposcopy market which can be attributed to the rapidly rising cases of cervical cancer in the region. Other key factors, like the technological advances in the healthcare sector, product launches of innovative colposcopes integrated with artificial intelligence, and the presence of pioneering medical device companies in the region are also expected to propel the growth of the market in the forecast period.
In Asia Pacific, various programs led by government and non-government organizations have bolstered the colposcopy market share, with the increased number of people seeking regular cervical cancer screening procedures including colposcopy. In November 2023 , the ROSE Foundation (a non-profit organization committed to eliminating cervical cancer in Malaysia) via its Program ROSE (Removing Obstacles to cervical ScrEening) celebrated a milestone in facilitating cervical cancer screening to over 25000 women, with 90% of women receiving appropriate follow-up examinations and treatments. To eliminate cervical cancer in Malaysia, the Foundation plans to implement a mobile colposcopy service in a remote village in Sarawak, a Malaysian state. The surge in such initiatives surrounding cervical cancer treatment are poised to elevate the application of colposcopes, boosting the market demand during the forecast period.
Global Colposcopy Market: Competitor Landscape
In November 2023 , Indonesia based medical devices companies such as PT Forsta Kalmedic Global, PT Kalgen DNA, PT Swayasa Prakarsa, and PT Prima Alkesindo Nusantara, made strategic collaborations and trade transactions amounting to IDR 363.08 billion (USD 21.5 million) during the 4 days of the world’s largest health equipment exhibition MEDICA 2023 event in Germany. The exhibition, boasting participation from over 6200 multinational companies, revealed the market expansion efforts of Indonesian medical device companies carrying a diverse product portfolio including colposcopy machines, bone graft equipment, etc. Such events of collaborations and investment are projected to increase the colposcopy market size in the forecast period.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Global Colposcopy Market Overview
A colposcopy is a diagnostic procedure to check any abnormal tissue growth in the lower part of the uterus (cervix) and the wall of the vagina. The procedure, usually lasting for 10 to 20 minutes, employs a specialized microscope called a colposcope to magnify the tissue, lining the cervix and vagina. In case any abnormalities are detected, a biopsy is done to test the tissue for precancerous or cancerous cells. Besides checking for cancerous cells, colposcopies can also be used to test for noncancerous growth (polyps), genital warts, vulvar itching, or abnormal vaginal bleeding.
The rising incidence of cervical cancer is acting as the key driver for colposcopy market growth. According to the report released by the World Health Organization (WHO), cervical cancer is the fourth most common cancer in women worldwide. It is also reported that women with human papillomavirus (HPV) are 6 times more prone to cervical cancer as compared to the ones without HPV infection. In addition, it is estimated that around 600,000 women suffer from cervical cancer caused by the sexually transmitted infection HPV, which has prompted the demand for effective screening procedures including colposcopy globally. Moreover, the robust government support to raise awareness about cervical cancers and the importance of colposcopy is expected to bolster the market growth in the coming years.
Development of Novel Colposcopy Products for Cervical Cancer Screening
The recent advancements in technology led to the development of digital and portable colposcopes, facilitating enhanced imaging capabilities and convenience. Additionally, the integration of artificial intelligence (AI) has substantially improved the speed and accuracy of the screening method. This has resulted in a spike in the number of patients opting for the diagnostic procedure, fueling the colposcopy market demand.
In May 2023 , MobileODT, an AI-based FemTech company in Israel introduced EVAPro next gen digital colposcope featuring high image quality with superior software capabilities. The lightweight and portable colposcope utilizes artificial intelligence and machine learning for cervical cancer screening on a large scale, offering quick evaluation (under a minute) and instant consultation. Thus, the novel product redefines cervical cancer screening as compared to the existing standard of care.
Increased Government Initiatives and Awareness Campaigns
Initiatives to raise awareness about the importance of colposcopy for early detection of cervical cancer by government, non-profit organizations, and healthcare facilities have boosted the colposcopy market share significantly.
In May 2023, the National Health Service (NHS), a publicly funded healthcare system in England, pledged to eliminate cervical cancer by 2040. The initiative aims to improve the accessibility of online vaccine appointments and encourage more people to undergo cervical screening, with 3.5 million tested in the last year. With the help of colposcopy teams, and immunization staff, among others, the NHS is actively working towards reducing the global burden of cervical cancer. The robust campaigns are reaching a wider audience, prompting them to adopt regular cervical cancer screening practices, which is likely to contribute to notable market growth in the forecast period.
Global Colposcopy Market Segmentation
Colposcopy Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Instrument Type
- Optical
- Digital
- Stationary
- Handheld
- Cervical Cancer Screening
- Physical Examinations
- Other Applications
- Hospitals & Clinics
- Diagnostic Centres
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America is anticipated to account for the largest share in the colposcopy market which can be attributed to the rapidly rising cases of cervical cancer in the region. Other key factors, like the technological advances in the healthcare sector, product launches of innovative colposcopes integrated with artificial intelligence, and the presence of pioneering medical device companies in the region are also expected to propel the growth of the market in the forecast period.
In Asia Pacific, various programs led by government and non-government organizations have bolstered the colposcopy market share, with the increased number of people seeking regular cervical cancer screening procedures including colposcopy. In November 2023 , the ROSE Foundation (a non-profit organization committed to eliminating cervical cancer in Malaysia) via its Program ROSE (Removing Obstacles to cervical ScrEening) celebrated a milestone in facilitating cervical cancer screening to over 25000 women, with 90% of women receiving appropriate follow-up examinations and treatments. To eliminate cervical cancer in Malaysia, the Foundation plans to implement a mobile colposcopy service in a remote village in Sarawak, a Malaysian state. The surge in such initiatives surrounding cervical cancer treatment are poised to elevate the application of colposcopes, boosting the market demand during the forecast period.
Global Colposcopy Market: Competitor Landscape
In November 2023 , Indonesia based medical devices companies such as PT Forsta Kalmedic Global, PT Kalgen DNA, PT Swayasa Prakarsa, and PT Prima Alkesindo Nusantara, made strategic collaborations and trade transactions amounting to IDR 363.08 billion (USD 21.5 million) during the 4 days of the world’s largest health equipment exhibition MEDICA 2023 event in Germany. The exhibition, boasting participation from over 6200 multinational companies, revealed the market expansion efforts of Indonesian medical device companies carrying a diverse product portfolio including colposcopy machines, bone graft equipment, etc. Such events of collaborations and investment are projected to increase the colposcopy market size in the forecast period.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- DYSIS Medical Inc.
- Olympus Corporation
- Kaps GmbH & Co. KG
- Carl Zeiss AG
- CooperSurgical, Inc
- Koninklijke Philips N.V.
- MedGyn Products, Inc.
- Danaher Corporation
- Schmitz Cargobull AG
- Seiler Instrument Inc.
- ATMOS MedizinTechnik GmbH & Co. KG
- MobileODT Ltd.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Colposcopy Market (218-2034) Overview
- 3.1 Global Colposcopy Market (2018-2034) Historical Value (2018-2024)
- 3.2 Global Colposcopy Market (2018-2034) Forecast Value (2025-2034)
- 4 Global Colposcopy Market (218-2034) Landscape
- 4.1 Global Colposcopy Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Colposcopy Product Landscape
- 4.2.1 Analysis by Instrument Type
- 4.2.2 Analysis by Application
- 5 Global Colposcopy Market (218-2034) Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Colposcopy Market (218-2034) Segmentation
- 6.1 Global Colposcopy Market (2018-2034) by Instrument Type
- 6.1.1 Market Overview
- 6.1.2 Optical
- 6.1.3 Digital
- 6.2 Global Colposcopy Market (2018-2034) by Portability
- 6.2.1 Market Overview
- 6.2.2 Stationary
- 6.2.3 Handheld
- 6.3 Global Colposcopy Market (2018-2034) by Application
- 6.3.1 Market Overview
- 6.3.2 Cervical Cancer Screening
- 6.3.3 Physical Examinations
- 6.3.4 Other Applications
- 6.4 Global Colposcopy Market (2018-2034) by End User
- 6.4.1 Market Overview
- 6.4.2 Hospitals & Clinics
- 6.4.3 Diagnostic Centres
- 6.4.4 Others
- 6.5 Global Colposcopy Market (2018-2034) by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Colposcopy Market (218-2034)
- 7.1 North America Colposcopy Market (2018-2034) by Instrument Type
- 7.1.1 Market Overview
- 7.1.2 Optical
- 7.1.3 Digital
- 7.2 North America Colposcopy Market (2018-2034) by Portability
- 7.2.1 Market Overview
- 7.2.2 Stationary
- 7.2.3 Handheld
- 7.3 North Colposcopy Market (2018-2034) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Colposcopy Market (218-2034)
- 8.1 Europe Colposcopy Market (2018-2034) by Instrument Type
- 8.1.1 Market Overview
- 8.1.2 Optical
- 8.1.3 Digital
- 8.2 Europe Colposcopy Market (2018-2034) by Portability
- 8.2.1 Market Overview
- 8.2.2 Stationary
- 8.2.3 Handheld
- 8.3 Europe Colposcopy Market (2018-2034) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Colposcopy Market (218-2034)
- 9.1 Asia Pacific Colposcopy Market (2018-2034) by Instrument Type
- 9.1.1 Market Overview
- 9.1.2 Optical
- 9.1.3 Digital
- 9.2 Asia Pacific Colposcopy Market (2018-2034) by Portability
- 9.2.1 Market Overview
- 9.2.2 Stationary
- 9.2.3 Handheld
- 9.3 Asia Pacific Colposcopy Market (2018-2034) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 Australia
- 9.3.5 ASEAN
- 9.3.6 Others
- 10 Latin America Colposcopy Market (218-2034)
- 10.1 Latin America Colposcopy Market (2018-2034) by Instrument Type
- 10.1.1 Market Overview
- 10.1.2 Optical
- 10.1.3 Digital
- 10.2 Latin America Colposcopy Market (2018-2034) by Portability
- 10.2.1 Market Overview
- 10.2.2 Stationary
- 10.2.3 Handheld
- 10.3 Latin America Colposcopy Market (2018-2034) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Colposcopy Market (218-2034)
- 11.1 Middle East and Africa Colposcopy Market (2018-2034) by Instrument Type
- 11.1.1 Market Overview
- 11.1.2 Optical
- 11.1.3 Digital
- 11.2 Middle East and Africa Colposcopy Market (2018-2034) by Portability
- 11.2.1 Market Overview
- 11.2.2 Stationary
- 11.2.3 Handheld
- 11.3 Middle East and Africa Colposcopy Market (2018-2034) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 DYSIS Medical Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Olympus Corporation
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Kaps GmbH & Co. KG
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Carl Zeiss AG
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 CooperSurgical, Inc
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Koninklijke Philips N.V.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 MedGyn Products, Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Danaher Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Schmitz Cargobull AG
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Seiler Instrument Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 ATMOS MedizinTechnik GmbH & Co. KG
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 MobileODT Ltd.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
